Pharma Journalist -

Alvogen and Zentiva Group a.s announced that Alvogen has signed a definitive agreement to sell its Central and Eastern European business to Zentiva, for an undisclosed amount.…
Read More...

Vertex Pharmaceuticals Incorporated announced an access agreement with NHS England for all currently licensed Vertex cystic fibrosis (CF) medicines and any future indications of these…
Read More...

Novartis announced that the European Commission (EC) has approved a label update for the up-titration of Cosentyx (secukinumab) to 300 mg for patients with active ankylosing spondylitis…
Read More...

Allergan plc announced that the U.S. Food and Drug Administration (FDA) approved the company's supplemental Biologics License Application (sBLA) for BOTOX for the treatment of pediatric…
Read More...

AZTherapies, Inc., a biopharmaceutical company developing therapeutics to extend brain health, announced the acquisition of Smith Therapeutics, a private biopharmaceutical company with…
Read More...

Foamix Pharmaceuticals Ltd. announced that it has entered into a long term contract manufacturing and supply agreement with ASM Aerosol-Service for the Company’s recently approved…
Read More...

AVROBIO announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation for the Company’s investigational gene therapy, AVR-RD-02, for the treatment of…
Read More...

SMi Reports: Karl Hess from OnDigitalHealth Consulting to present at Disruptive Technologies in Pharma conference in London on the 20th and 21st January SMi is delighted to present…
Read More...

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis, announced it has entered into…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a Type II Variation Application to the European Medicines Agency (EMA) seeking first-in-class…
Read More...